Literature DB >> 15000293

How could aortic arginase activity enhancement be involved in DOCA-salt hypertension?

S Rodriguez1, R Schleiffer, F Raul, L Richert, A Berthelot.   

Abstract

This study was to examine whether the increase in aortic arginase activity observed in DOCA-salt hypertensive rats is involved in the mechanism of physiological hypertension by participating to vessel hypertrophy and/or to the impairment of endothelium-dependent relaxation to acethylcholine. We measured polyamine content and relaxation-response to acethylcholine in aortic rings isolated from control and DOCA-salt treated Sprague-Dawley rats after in vitro modification of arginase activity. Polyamine content was significantly increased in aorta from DOCA-salt hypertensive rats compared with controls. In the normotensive rats, the addition of L-valine (an inhibitor of arginase) decreased the relaxation response to acethylcholine whereas the addition of arginase increased the relaxation dependent response. On the contrary, in DOCA-salt hypertensive rats, the addition of L-valine or of arginase did not change the endothelium dependent relaxation. The results obtained suggest that the increase in aortic arginase activity in DOCA-salt hypertension could contribute to vascular hypertrophy but not to the impairment of endothelium-dependent relaxation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15000293     DOI: 10.1081/ceh-120027327

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  1 in total

1.  The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries.

Authors:  N N Huynh; E E Harris; J F P Chin-Dusting; K L Andrews
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.